Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study

Matthias B. Moor, Franziska Suter‐Riniker, Michael P. Horn, Daniel Aeberli, Jennifer Amsler, Burkhard Möller, Linet Njue, Cesare Medri, Anne Angelillo‐Scherrer, Luca Borradori, Susanne Radonjic‐Hoesli, S. Morteza Seyed Jafari, Andrew Chan, Robert Hoepner, Vera Ulrike Bacher, Laila‐Yasmin Mani, Joseena Iype, Cédric Hirzel, Britta Maurer, Daniel Sidler